Skip to content
Wenlo
Sign in
← Markets

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc. (LSTA) — Form 8-K/A: Current report (amendment)

8-K/ALSTAFiled Nov 12, 2026, 1:07 AM ET· Period Sep 17, 2026

About this filing

Lisata Therapeutics, Inc. (LSTA) filed an amended 8-K on Nov 12, 2026 reporting financial statements and exhibits (Item 9.01).

Key facts

  • Item 9.01 · Financial statements and exhibits

More LSTA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.